Sign In
Free Newsletter
May 11, 2020
VCU tests third COVID-19 drug, this time targeting inflammation
Researchers at VCU Health now are conducting trials on a third drug to help treat COVID-19, a medication that suppresses inflammation in people with a type of juvenile arthritis. Canakinumab is already approved by the U.S. Food and Drug Administration for use in arthritis patients, but a new study — launched April 29 at VCU […]
